Episode – Investing in Biotech
Hosted by Horizon 3 Biotech Investment Committee Member Dr Tam Nguyen. In this episode Tam talks to Michelle Gallaher from Opyl and Dr Stefan Harrer
Hosted by Horizon 3 Biotech Investment Committee Member Dr Tam Nguyen. In this episode Tam talks to Michelle Gallaher from Opyl and Dr Stefan Harrer
Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara In this episode Matt will be joined by Dr Megan Baldwin, CEO and Managing Director
Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara In this episode Matt will be joined by John Melki CEO of Genetic Signatures, Dr
Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara In this episode Matt will be joined by Dr Chris Baldwin, Deputy CEO and Chief
Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara In this episode Matt will be joined by Simon Davidson from Lander & Rogers and
Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara In this episode Matt will be joined by Rosemary Cummins of MST Financial and Ralph
Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara In this episode Matt will be joined by Tony Locantro from Alto Capital and Sue
Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara In this episode Matt will be joined by Investment Analyst Scott Power at Morgans to
Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara Matt MacNamara, Chief Investment Officer at Horizon 3 Biotech & Scott Power, Investment Committee at
Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara Matt MacNamara, Chief Investment Officer at Horizon 3 Biotech &Â Scott Power, Investment Committee at
Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara In this episode Matt will be joined by Chris Behrenbruch from Telix Pharmaceuticals and David
Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara In this episode Matt will be joined by Opthea CEO & Managing Director Dr Megan
Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara In this episode Matt will be joined by Horizon 3 Biotech Life Sciences and Capital
This Guide to Life Sciences Investing, with foreword from Horizon 3’s Board member Glenn Cross, will provide potential investors in life sciences companies with consolidated, factual,
Recent News
Email your message to H3 Healthcare